Overview

Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate preparation and administration of PB127, echocardiographic images obtained during PB127 administration, and evaluate the safety of PB127.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Point Biomedical